Our results seem to confirm and establish the trend in the meta-analysis of p21 3′ UTR rs1059234 polymorphism and SCCHN risk that the data by Li et al.7 had indicated. The gene discussed is CDKN1A; the disease is head and neck squamous cell carcinoma.